UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 401

Sortiert nach

L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation

JNCI : Journal of the National Cancer Institute, 2013-08, Vol.105 (15), p.1142-1150

2013

Volltextzugriff (PDF)

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

BMC cancer, 2016-02, Vol.16 (103), p.102-102, Article 102

2016

Volltextzugriff (PDF)

Multifunctional Hybrid Material for Endoprosthetic Implants Based on Alumina-Toughened Zirconia Ceramics and Additively Manufactured TiNbTa Alloys

Materials, 2024-04, Vol.17 (8), p.1838

2024

Volltextzugriff (PDF)

Stratification of Homologous Recombination Deficiency-Negative High-Grade Ovarian Cancer by the Type of Peritoneal Spread into Two Groups with Distinct Survival Outcomes

Cancers, 2024-06, Vol.16 (11), p.2129

2024

Volltextzugriff (PDF)

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer

Scientific reports, 2020-11, Vol.10 (1), p.20412-20412, Article 20412

2020

Volltextzugriff (PDF)

Toll‐like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

Cancer science, 2010-04, Vol.101 (4), p.1059-1066

2010

Volltextzugriff (PDF)

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers

BMC cancer, 2016-08, Vol.16 (1), p.589-589, Article 589

2016

Volltextzugriff (PDF)

DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer

Gynecologic oncology, 2011-04, Vol.121 (1), p.24-31

2011

Volltextzugriff (PDF)

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)

Advances in therapy, 2018-11, Vol.35 (11), p.2054-2068

2018

Volltextzugriff (PDF)

Clinical Relevance of E2F Family Members in Ovarian Cancer—An Evaluation in a Training Set of 77 Patients

Clinical cancer research, 2007-01, Vol.13 (1), p.144-151

2007

Volltextzugriff (PDF)

The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer

International journal of gynecological cancer, 2012-03, Vol.22 (3), p.372-379

2012

Volltextzugriff (PDF)

Expression of the E2F Family of Transcription Factors and Its Clinical Relevance in Ovarian Cancer

Annals of the New York Academy of Sciences, 2006-12, Vol.1091 (1), p.270-281

2006

Volltextzugriff (PDF)

Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo

Clinical cancer research, 2005-12, Vol.11 (23), p.8372-8383

2005

Volltextzugriff (PDF)

DyeCycle violet used for side population detection is a substrate of P‐glycoprotein

Cytometry. Part A, 2012-06, Vol.81A (6), p.517-522

2012

Volltextzugriff (PDF)

Pros and Cons of Intraperitoneal Chemotherapy in the Treatment of Epithelial Ovarian Cancer

Anticancer research, 2009-07, Vol.29 (7), p.2803-2808

2009

Volltextzugriff (PDF)

An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer

Gynecologic oncology, 2023-03, Vol.170, p.290-299

2023

Volltextzugriff (PDF)

High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome

International journal of cancer, 2020-04, Vol.146 (7), p.2007-2018

2020

Volltextzugriff (PDF)

Role of BRCA1 promotor methylation ( BRCA1 meth ) in homologous recombination deficiency (HRD) in high-grade epithelial ovarian cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17592-e17592

2023

Volltextzugriff (PDF)

Laparoscopic versus open-surgery in FIGO stage II endometrioid endometrium cancers: Is there a prognostic effect?

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.5605-5605

2023

Volltextzugriff (PDF)

Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche

Biochimica et biophysica acta, 2016-12, Vol.1866 (2), p.276-289

2016

Volltextzugriff (PDF)

Comprehensive HRD testing in epithelial ovarian cancer: A further step toward personalized therapy decisions

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17591-e17591

2023

Volltextzugriff (PDF)

Ovarian Cancer Stem Cell Heterogeneity

Advances in experimental medicine and biology, 2019-01, Vol.1139, p.201-221

2019

Volltextzugriff (PDF)

Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer

Acta obstetricia et gynecologica Scandinavica, 2020-08, Vol.99 (8), p.1092-1099

2020

Volltextzugriff (PDF)

Activated p38-MAPK and Gemcitabine Sensitivity in Recurrent Ovarian Cancer

Anticancer research, 2008-09, Vol.28 (5B), p.2975-2980

2008

Volltextzugriff (PDF)

(Iso‐)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer

The oncologist (Dayton, Ohio), 2018-07, Vol.23 (7), p.757-759

2018

Volltextzugriff (PDF)

1 – 25 von 401

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(334)
Mit Volltextzugriff
(368)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(218)
Life Sciences & Biomedicine
(143)
Humans
(116)
Female
(80)
Middle Aged
(57)
Aged
(48)
Male
(42)
Oncology
(42)
Animals
(38)
Adult
(36)
Technology
(35)
Physical Sciences
(34)
Science & Technology - Other Topics
(31)
Ovarian Cancer
(29)
Multidisciplinary Sciences
(28)
Biological And Medical Sciences
(22)
Medicine
(22)
Prognosis
(22)
Medical Sciences
(20)
Engineering
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

L1CAM in Early-Stage Type I Endometrial Cancer: Results of a Large Multicenter Evaluation

Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer

Multifunctional Hybrid Material for Endoprosthetic Implants Based on Alumina-Toughened Zirconia Ceramics and Additively Manufactured TiNbTa Alloys

Stratification of Homologous Recombination Deficiency-Negative High-Grade Ovarian Cancer by the Type of Peritoneal Spread into Two Groups with Distinct Survival Outcomes

Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer

Toll‐like receptor 9 expression in breast and ovarian cancer is associated with poorly differentiated tumors

Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers

DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer

Calgranulin A (S100A8) Immunostaining: A Future Candidate for Risk Assessment in Patients with Non-Muscle-Invasive Bladder Cancer (NMIBC)

Clinical Relevance of E2F Family Members in Ovarian Cancer—An Evaluation in a Training Set of 77 Patients

The N-Terminally Truncated p53 Isoform Δ40p53 Influences Prognosis in Mucinous Ovarian Cancer

Expression of the E2F Family of Transcription Factors and Its Clinical Relevance in Ovarian Cancer

Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo

DyeCycle violet used for side population detection is a substrate of P‐glycoprotein

Pros and Cons of Intraperitoneal Chemotherapy in the Treatment of Epithelial Ovarian Cancer

An angiogenic tumor phenotype predicts poor prognosis in ovarian cancer

High RIG‐I expression in ovarian cancer associates with an immune‐escape signature and poor clinical outcome

Role of BRCA1 promotor methylation ( BRCA1 meth ) in homologous recombination deficiency (HRD) in high-grade epithelial ovarian cancer

Laparoscopic versus open-surgery in FIGO stage II endometrioid endometrium cancers: Is there a prognostic effect?

Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche

Comprehensive HRD testing in epithelial ovarian cancer: A further step toward personalized therapy decisions

Ovarian Cancer Stem Cell Heterogeneity

Enlarged cardiophrenic lymph nodes predict disease involvement of the upper abdomen and the outcome of primary surgical debulking in advanced ovarian cancer

Activated p38-MAPK and Gemcitabine Sensitivity in Recurrent Ovarian Cancer

(Iso‐)form Matters: Differential Implication of Vav3 Variants in Ovarian Cancer

Suchergebnisse filtern